We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

86 hedge funds and large institutions have $32.3M invested in Spectrum Pharmaceuticals Inc in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,271% more call options, than puts

Call options by funds: $480K | Put options by funds: $35K

15% less funds holding

Funds holding: 101 → 86 (-15)

20% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 25

42% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 31

65% less capital invested

Capital invested by funds: $92.5M → $32.3M (-$60.2M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
86
Holders Change
-15
Holders Change %
-14.85%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
20
Reduced
25
Closed
31
Calls
$480K
Puts
$35K
Net Calls
+$445K
Net Calls Change
+$97K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.7M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$762K
3
Citadel Advisors
Citadel Advisors
Florida
+$653K
4
E
Ergoteles
New York
+$392K
5
US Bancorp
US Bancorp
Minnesota
+$343K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$6.97M
2
State Street
State Street
Massachusetts
-$2.31M
3
PAM
Panagora Asset Management
Massachusetts
-$1.09M
4
Northern Trust
Northern Trust
Illinois
-$1.01M
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$874K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.89M +$762K +864,894 +11%
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$6.28M +$182K +206,132 +3%
BlackRock
3
BlackRock
New York
$6.15M -$6.97M -7,911,020 -50%
Millennium Management
4
Millennium Management
New York
$2.09M +$1.7M +1,923,371 +254%
Morgan Stanley
5
Morgan Stanley
New York
$1.39M +$111K +125,821 +8%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$1.35M -$874K -991,807 -36%
Renaissance Technologies
7
Renaissance Technologies
New York
$929K -$188K -212,990 -15%
ACM
8
Alethea Capital Management
Washington
$615K -$343K -389,142 -33%
Citadel Advisors
9
Citadel Advisors
Florida
$589K +$653K +741,215 +5,327%
E
10
Ergoteles
New York
$581K +$392K +445,270 +149%
State Street
11
State Street
Massachusetts
$563K -$2.31M -2,616,547 -78%
SIG
12
Sargent Investment Group
Maryland
$479K +$176K +200,000 +48%
CM
13
CM Management
Florida
$468K – – –
Fisher Asset Management
14
Fisher Asset Management
Washington
$425K – – –
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$358K -$61.7K -70,060 -13%
Wells Fargo
16
Wells Fargo
California
$340K -$25K -28,335 -6%
US Bancorp
17
US Bancorp
Minnesota
$304K +$343K +389,142 New
Northern Trust
18
Northern Trust
Illinois
$255K -$1.01M -1,144,816 -78%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$238K +$36.3K +41,228 +16%
Goldman Sachs
20
Goldman Sachs
New York
$215K +$24.8K +28,092 +11%
AQR Capital Management
21
AQR Capital Management
Connecticut
$126K +$112K +127,252 +368%
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
$121K +$136K +154,597 New
GCM
23
Graham Capital Management
Connecticut
$115K +$130K +147,758 New
TCM
24
Tekla Capital Management
Massachusetts
$89K – – –
CANY
25
Caxton Associates (New York)
New York
$84K – – –
1
2 3 4 5

SPPI Hedge Fund Activity: Q2 2022 in Review

86 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2022, worth a combined $32.3M — down 65% from $92.5M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of SPPI and 18 opened new positions — a net loss of 13 holders — while 25 trimmed existing stakes and 20 added.

The largest buyer was Millennium Management, adding an estimated $1.7M. The largest seller was BlackRock, cutting an estimated $6.97M.

  • 86 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2022, down from 101 in Q1 2022.
  • Funds reported $32.3M of Spectrum Pharmaceuticals Inc stock for Q2 2022, down 65% quarter-over-quarter.
  • 18 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2022 and 31 closed out, a net change of -13 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2022 was Millennium Management, an estimated $1.7M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2022 was BlackRock, an estimated $6.97M sold.

Based on aggregated 13F filings for Q2 2022.